Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product
News of the Successful Trial Comes Amid an Oversubscribed Investor Round and Preparation for Series A Financing Round Belhaven Biopharma, a leader in innovative treatments...
Belhaven Biopharma Achieves Significant Milestones in Advancing Nasdepi – a Revolutionary Nasal Dry Powder Epinephrine Product
Several key accomplishments completed to finish 2023 and create a strong foundation for 2024. Belhaven Biopharma, a pioneering force in the development of emergency-use epinephrine...